Quest Diagnostics (DGX) Short term Debt: 2009-2025
Historic Short term Debt for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $504.0 million.
- Quest Diagnostics' Short term Debt fell 16.42% to $504.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $504.0 million, marking a year-over-year decrease of 16.42%. This contributed to the annual value of $602.0 million for FY2024, which is 98.68% up from last year.
- Quest Diagnostics' Short term Debt amounted to $504.0 million in Q3 2025, which was down 0.00% from $504.0 million recorded in Q2 2025.
- Quest Diagnostics' Short term Debt's 5-year high stood at $906.0 million during Q1 2024, with a 5-year trough of $1.0 million in Q3 2021.
- Moreover, its 3-year median value for Short term Debt was $504.0 million (2025), whereas its average is $441.2 million.
- Per our database at Business Quant, Quest Diagnostics' Short term Debt soared by 45,200.00% in 2024 and then slumped by 99.89% in 2025.
- Quarterly analysis of 5 years shows Quest Diagnostics' Short term Debt stood at $2.0 million in 2021, then remained steady at $2.0 million in 2022, then soared by 15,050.00% to $303.0 million in 2023, then surged by 98.68% to $602.0 million in 2024, then declined by 16.42% to $504.0 million in 2025.
- Its Short term Debt stands at $504.0 million for Q3 2025, versus $504.0 million for Q2 2025 and $1.0 million for Q1 2025.